Scientists including one from The University of Texas Health Science Center at Houston successfully predicted the outcome of a nano drug on breast tumors in a pre-clinical study. Their research could help determine which patients will respond best to cancer-fighting nano drugs. Researchers from the Georgia Institute of Technology and Emory University also participated in the study, which appears in the February issue of Radiology.
More...